SUPRATHERAPEUTIC UNFRACTIONATED HEPARIN ANTI-XA LEVELS DUE TO TREATMENT-DOSE ENOXAPARIN EXPOSURE

被引:0
|
作者
Anthes, Ananth
Providence, Sarah
Wilmer, Carrie [1 ]
Zhao, Xinhua [2 ]
Aspinall, Sherrie [3 ]
机构
[1] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[2] Ctr Hlth Equ Res & Promot, Pittsburgh, PA USA
[3] VA Ctr Medicat Safety, Pharm Benefits Management Serv, Hines, IL USA
关键词
D O I
10.1097/01.ccm.0000810088.32788.fb
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
941
引用
收藏
页码:467 / 467
页数:1
相关论文
共 50 条
  • [1] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin
    Gibson, JL
    Ekevall, K
    Walker, I
    Greer, IA
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (07): : 795 - 797
  • [2] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin
    Laifer, SA
    Casele, HL
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (06): : 614 - 615
  • [3] Evaluating residual anti-Xa levels following discontinuation of treatment-dose enoxaparin in patients presenting for elective surgery: an infographic
    Henshaw, Daryl S.
    Schwenk, Eric S.
    Gupta, Rajnish K.
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2024, 49 (02) : 102 - 103
  • [4] Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin - Reply
    Greer, IA
    Walker, ID
    Gibson, JE
    Ekevall, K
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (06): : 615 - 615
  • [5] Risk Stratification for Supratherapeutic Peak Anti-Xa Levels in Adult Patients on Therapeutic Enoxaparin
    Sheredy, Shane A.
    Stone, Andrew C.
    Mostafavifar, Ahmad M.
    Mostafavifar, Lisa G.
    Smith, Rachel M.
    Doepker, Bruce A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2024, 58 (04) : 366 - 374
  • [6] Evaluating residual anti-Xa levels following discontinuation of treatment-dose enoxaparin in patients presenting for elective surgery: a prospective observational trial
    Henshaw, Daryl S.
    Edwards, Christopher J.
    Dobson, Sean W.
    Jaffe, Doug
    Turner, James D.
    Reynolds, J. Wells
    Thompson, Garrett R.
    Russell, Greg
    Weller, Robert
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2024, 49 (02) : 94 - 101
  • [7] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    [J]. THROMBOSIS RESEARCH, 1997, 85 (03) : 259 - 265
  • [8] Very low doses of unfractionated heparin potentiate the anti-Xa activity of low molecular weight heparin (Enoxaparin)
    PerezRequejo, JL
    LucenaSolano, O
    PerezGarcia, M
    Santarelli, MT
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : P1172 - P1172
  • [9] Intravenous unfractionated heparin dosing in obese patients using anti-Xa levels
    Alex M. Ebied
    Tammy Li
    Samantha F. Axelrod
    Douglas J. Tam
    Yiqing Chen
    [J]. Journal of Thrombosis and Thrombolysis, 2020, 49 : 206 - 213
  • [10] Intravenous unfractionated heparin dosing in obese patients using anti-Xa levels
    Ebied, Alex M.
    Li, Tammy
    Axelrod, Samantha F.
    Tam, Douglas J.
    Chen, Yiqing
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 49 (02) : 206 - 213